|
|
Line 85: |
Line 85: |
| *'''Pregnant or Breastfeeding Women''': There is limited research on the safety of TMG supplementation during pregnancy and breastfeeding; thus, consultation with a healthcare professional is advised. | | *'''Pregnant or Breastfeeding Women''': There is limited research on the safety of TMG supplementation during pregnancy and breastfeeding; thus, consultation with a healthcare professional is advised. |
| *'''Pre-existing Health Conditions''': Individuals with pre-existing health conditions, particularly those affecting the liver, should consult a healthcare professional before beginning TMG supplementation. | | *'''Pre-existing Health Conditions''': Individuals with pre-existing health conditions, particularly those affecting the liver, should consult a healthcare professional before beginning TMG supplementation. |
| ==Studies==
| |
| Protective effects of TMG in experimental animal models, cell culture systems, and clinical studies.
| |
| {| class="wikitable"
| |
| !Therapeutic Effects of TMG Administration
| |
| !Experimental Model
| |
| !{{VerticalText|Heart Health and Homocysteine Levels}}
| |
| !{{VerticalText|Liver Function and Detoxification}}
| |
| !{{VerticalText|Stress Resistance and Cellular Hydration}}
| |
| !{{VerticalText|Support in Metabolic Processes}}
| |
| !{{VerticalText|Mood and Well-being}}
| |
| |-
| |
| |Prevents hepatic fat accumulation in ALD
| |
| |Male [[Wistar rats]]; [[C57BL/6 mice]]; [[BALB/c mice]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Preserves/restores hepatic SAM: SAH ratios by regenerating SAM and lowering SAH and homocysteine levels in ALD
| |
| |Male [[Wistar rats]]; hepatocytes; male [[C57BL/6 mice]]
| |
| | X
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Restores activities of various liver methyltransferases (PEMT, ICMT, PIMT, PRMT) to increase phosphatidylcholine levels, preventing apoptosis and accumulation of damaged proteins, and restoring proteasome activity
| |
| |Male [[Wistar rats]]; hepatocytes
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Suppresses the synthesis of DGAT2, a rate-limiting enzyme in triglyceride synthesis, by alleviating ERK1/2 inhibition in ALD
| |
| |Male [[C57BL/6 mice]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Upregulates antioxidant defense system and improves oxyradical scavenging activity in ALD
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Prevents/attenuates ER stress in ALD
| |
| | Male [[C57BL/6 mice]]
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| | Exerts hepatoprotection by preserving mitochondrial function in ALD
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Restores the serum adiponectin levels in ALD
| |
| |Mice
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Prevents elevations of CD14, TNFα, COX2, GADD45β, LITAF, JAK3, TLR2, TLR4, IL1β, and PDCD4 and NOS2 mRNA levels in alcoholic liver injury
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Prevents serum ALT and AST activity elevations in models of ALD and MAFLD
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Reduces liver oxidant stress, inflammation, and apoptosis in MAFLD
| |
| | Male [[C57BL/6 mice]]
| |
| |
| |
| | X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Remethylates homocysteine, protecting from oxidant stress and restoring phosphatidylcholine generation in MAFLD
| |
| |[[C57BL/6 mice]]
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Stimulates β-oxidation in livers of MCD diet-induced MAFLD
| |
| |Male [[Sprague-Dawley rats]]
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Alleviates steatosis and increases autophagosomes numbers in mouse livers with MAFLD
| |
| | Male [[C57BL/6 mice]]; rats
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Enhances the conversion of existing WAT to brown adipose tissue through stimulating mitochondrial biogenesis in MAFLD
| |
| | Mice
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Alleviates ROS-induced mitochondrial respiratory chain dysfunction in MAFLD
| |
| |Male [[Sprague-Dawley rats]]
| |
| |
| |
| |X
| |
| |X
| |
| |X
| |
| |
| |
| |-
| |
| |Attenuates different grades of steatosis, inflammation, and fibrosis in MAFLD patients
| |
| |Human trials
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Prevents adipose tissue dysfunction in ALD
| |
| | Male [[C57BL/6 mice]]
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Reduces the inflammatory adipokines, IL6, TNFα, and leptin in human adipocytes
| |
| |Human visceral adipocytes
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |X
| |
| |-
| |
| | Inhibits lipid peroxidation, hepatic inflammation, and expression of transforming growth factor-β1 in liver fibrosis
| |
| |Male chicks
| |
| |
| |
| |X
| |
| | X
| |
| |
| |
| |
| |
| |-
| |
| |Suppresses alcoholic liver fibrosis
| |
| |Rats
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Prevents the formation of Mallory–Denk bodies through epigenetic means by attenuating the decrease of MAT1A, SAHH, BHMT, and AMD1 expression
| |
| |Male [[C3H mice]]
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Reverses the inhibitory effects of acetaldehyde on IFN signaling and decreases de-methylation of STAT1 by JMJD6
| |
| |HCV-infected Huh7.5 CYP2E1 (+) cells and human hepatocytes
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Enhances expression of PPARα and elevates fatty acid catabolism
| |
| |Male [[C57BL/6 mice|C57BL/6]] and [[ApoE−/− mice]]
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Inhibits lipogenic activity in liver by activation of AMPK
| |
| |[[ApoE−/− mice]]; Male [[C57BL/6 mice]]
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Regulates colonic fluid balance
| |
| |Rats
| |
| |
| |
| |
| |
| |
| |
| |X
| |
| |X
| |
| |-
| |
| |Improves intestinal barrier function and maintains the gut microbiota
| |
| |Porcine epithelial cells; Caco-2 cells; rat small intestinal cell line IEC-18
| |
| |
| |
| |
| |
| |
| |
| |X
| |
| |X
| |
| |-
| |
| |Activates GI digestive enzymes and ameliorates intestinal morphology and microbiota dysbiosis
| |
| |Male [[Sprague Dawley rats]]
| |
| |
| |
| |
| |
| |
| |
| |X
| |
| |X
| |
| |-
| |
| |Attenuates alcoholic-induced pancreatic steatosis
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Associated with resilience to anhedonia and prevention of stress-related psychiatric disorders
| |
| |Male [[C57BL/6 mice]]
| |
| |
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |-
| |
| |Treats asthma-induced oxidative stress, thus improving airway function of lung tissue
| |
| |[[BALB/c mice]]
| |
| |
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Protects against cadmium nephrotoxicity
| |
| |Male [[Wistar rats]]
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Protects against isoprenaline-induced myocardial dysfunction
| |
| |Male [[Wistar rats]]
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Anti-nociceptive and sedative role via interactions with opioidergic and GABA receptors
| |
| |Male albino mice
| |
| |
| |
| |
| |
| |X
| |
| |
| |
| |X
| |
| |-
| |
| |Normalizes fetal growth and reduces adiposity of progeny from obese mice
| |
| |[[C57BL/6 mice|C57BL/6J mice]]
| |
| |
| |
| |
| |
| |
| |
| |X
| |
| |
| |
| |-
| |
| |Anti-cancer effect in alcohol-associated breast cancer cell growth and development
| |
| |Breast adenocarcinoma cell line (MCF-7)
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |
| |
| |-
| |
| |Reduces rectal temperature in broiler chickens
| |
| |Chickens
| |
| |
| |
| |
| |
| |X
| |
| |
| |
| |
| |
| |-
| |
| |Improves post-natal lamb survival
| |
| |Lambs
| |
| |
| |
| |
| |
| |X
| |
| |X
| |
| |
| |
| |}
| |
|
| |
| ==See also== | | ==See also== |
|
| |
|